Big Babies May Face Higher Lifelong A-Fib Risk

MONDAY, Oct. 19, 2020 — Parents are usually pleased when their newborn seems big and strong, but new research suggests that large babies may be at higher risk for the heart rhythm disorder atrial fibrillation later in life. Atrial fibrillation (a-fib) is the most common heart rhythm disorder, affecting more than 40 million people worldwide. […]

Continue Reading

Newer Rheumatoid Arthritis Drug May Help Ease Tough-to-Treat Cases

MONDAY, Oct. 19, 2020 — A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treated with a standard disease-modifying antirheumatic drug (DMARD), […]

Continue Reading

NIH begins large clinical trial to test immune modulators for treatment of COVID-19

The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which the immune system unleashes excessive amounts of proteins that trigger inflammation – called a “cytokine storm” – […]

Continue Reading

How to Keep High Blood Pressure at Bay

News Consumer News How to Keep High Blood Pressure at Bay SATURDAY, Oct. 17, 2020 — To mark World Hypertension Day this Saturday, the American Heart Association offers advice on how to lower and control your blood pressure. High blood pressure affects nearly half of American adults, and three-quarters of those with high blood pressure […]

Continue Reading

Your Pooch’s Personality Can Change With Age

FRIDAY, Oct. 16, 2020 — Just like people, dogs’ personalities change as they age, a new European study suggests. “Even though dog personality is a highly popular topic in the literature, there are still gaps about the long-term stability, as well as about the dynamics of personality development,” said study first author Borbála Turcsán of […]

Continue Reading

New Drug Could Extend Life for People With ALS

FRIDAY, Oct. 16, 2020 — An experimental drug combination lengthens survival for patients with amyotrophic lateral sclerosis (ALS), new research shows. A previous clinical trial found that the two-drug combo — called AMX0035 — slowed progression of the neurodegenerative disease over six months. The new clinical trial of 137 patients with the disease, also known […]

Continue Reading